Apollo Endosurgery, Inc.
7000 Bee Caves Road
Suite 350
Austin
Texas
78746
United States
Tel: 512-328-9990
Fax: 512-328-9994
Website: http://www.apolloendo.com/
Email: barbara@ApolloEndo.com
150 articles about Apollo Endosurgery, Inc.
-
Apollo Endosurgery Announces Two Important Milestones in the Advancement of Endoscopic Procedures for Patients Living with Obesity
12/13/2022
Apollo Endosurgery, Inc. announced today that the MERIT trial, published in The Lancet earlier this year (1), was selected as 2022 Top Story in Gastroenterology.
-
Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.
11/29/2022
Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Apollo Endosurgery, Inc. (Nasdaq: APEN) for a cash price of $10 per share, reflecting an enterprise value of approximately $615 million.
-
Apollo Endosurgery, Inc. Reports Record $19.6 million Global Revenue in Third Quarter 2022
11/1/2022
Apollo Endosurgery, Inc., a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced financial results for the third quarter ended September 30, 2022 and recent corporate highlights.
-
Apollo Endosurgery to Report Third Quarter Results on November 1, 2022
10/18/2022
Apollo Endosurgery, Inc. today announced that the Company is scheduled to release financial results for the third quarter ended September 30, 2022 on Tuesday, November 1, 2022, after market close.
-
Endoscopic Sleeve Gastroplasty (ESG) Procedure Featured as a "Top 10" Paper at the IFSO 2022 World Congress in Miami
8/31/2022
Apollo Endosurgery, Inc. announced that the endoscopic sleeve gastroplasty procedure was featured in a 2022 Top 10 Paper at the International Federation for the Surgery of Obesity and Metabolic Disorders 2022 World Congress, held August 23-27 in Miami.
-
Apollo Endosurgery, Inc. Reports Record Global Revenue in Second Quarter 2022
8/2/2022
Apollo Endosurgery, Inc., a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced financial results for the second quarter ended June 30, 2022 and recent corporate highlights.
-
Apollo Endosurgery Announces Publication in the Lancet of Landmark Study for the Endoscopic Sleeve Gastroplasty Procedure
7/29/2022
Apollo Endosurgery, Inc. announced today the electronic publication of the landmark Multi-center ESG Randomized Interventional Trial (MERIT) Study in The Lancet .
-
Apollo Endosurgery to Report Second Quarter Results on August 2, 2022
7/21/2022
Apollo Endosurgery, Inc. today announced that the Company is scheduled to release financial results for the second quarter ended June 30, 2022 on Tuesday, August 2, 2022, after market close.
-
FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG(TM) and Apollo REVISE(TM), New Endoscopic Systems for Patients with Obesity
7/13/2022
Apollo Endosurgery, Inc. announced today the marketing authorization of the Apollo ESG TM, Apollo ESG Sx TM, Apollo REVISE TM and Apollo REVISE Sx TM Systems through the U.S. Food and Drug Administration's (FDA) De Novo Classification process, a rigorous pre-market review pathway for low-to moderate-risk devices without a predicate.
-
Sharon O'Keefe Joins Apollo Endosurgery Board of Directors
7/6/2022
Apollo Endosurgery, Inc. announced that Sharon O'Keefe has joined the company's Board of Directors, effective July 6, 2022.
-
Digestive Disease Week 2022 Adds to the Growing Wave of Clinical Evidence Supporting Significant Opportunity for Apollo Endosurgery Products
5/31/2022
Apollo Endosurgery, Inc. announced highlights today from data presented at Digestive Disease Week May 21-24.
-
Apollo Endosurgery Products to Take Center Stage at Digestive Disease Week
5/18/2022
Apollo Endosurgery, Inc. a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced today that Apollo products and procedures that utilize Apollo products will be featured in more than 40 academic posters and videos and over 60 podium presentations and lectures at the upcoming Digestive Disease Week 2022 to be held in San Diego, May 21-24.
-
Apollo Endosurgery, Inc. Reports 33% U.S. Revenue Growth in First Quarter 2022
5/3/2022
Apollo Endosurgery, Inc., a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced financial results for the first quarter ended March 31, 2022 and recent corporate highlights.
-
Apollo Endosurgery to Report First Quarter Results on May 3, 2022
4/13/2022
Apollo Endosurgery, Inc. announced that the Company is scheduled to release financial results for the first quarter ended March 31, 2022 on Tuesday, May 3, 2022, after market close.
-
Apollo Endosurgery Appoints Jeannette Bankes to Board of Directors
4/4/2022
Apollo Endosurgery, Inc. today announced the appointment of Jeannette Bankes to its Board of Directors, bringing the number of board members to eight.
-
Apollo Endosurgery to Participate in the Cowen Healthcare Conference
3/2/2022
Apollo Endosurgery, Inc. today announced that Chas McKhann, CEO, and Jeff Black, CFO, will host investor meetings March 7-8, 2022 as part of the Cowen Healthcare Conference, taking place virtually.
-
Apollo Endosurgery, Inc. Reports 50% Revenue Growth in 2021
2/22/2022
Apollo Endosurgery, Inc., a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced financial results for the fourth quarter and year ended December 31, 2021 and corporate highlights.
-
Apollo Endosurgery to Report Fourth Quarter and Full Year Results on February 22, 2022
2/10/2022
Apollo Endosurgery, Inc., a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, announced that the Company is scheduled to release financial results for the fourth quarter and full year ended December 31, 2021 on Tuesday, February 22, 2022, after market close.
-
Apollo Endosurgery Appoints Keely Scamperle as Vice President of Reimbursement and Market Access
1/18/2022
Apollo Endosurgery, Inc. today announced the hiring of Keely Scamperle as Vice President, Reimbursement & Market Access, effective January 17, 2022.
-
Apollo Endosurgery Announces Preliminary 2021 Revenue Results; Reflecting 50% Growth Over 2020
1/10/2022
Apollo Endosurgery, Inc. today announced preliminary unaudited revenue results for the fourth quarter and full year ended December 31, 2021.